DNA Prime/Subunit Boost Using SIV (E660) Based rhFLSC Yields 75% Efficacy Against Cross Clade SIVmac251 Intrarectal Challenge
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES(2013)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES(2013)